Stavros Papadopoulos, founder and CEO of TileDB, spoke with Pharmaceutical Executive about how modern databases are struggling to handle life sciences data, which in turn limits scientific discovery.

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Fintel reports that on February 13, 2025, Leerink Partners downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from ...

Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered price targets amid profitability concerns.

A Wednesday night earnings report left big questions about how the spending reductions would affect the company.

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

Researchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds.   - The regeneration process requires the activation ...

Following an international search, Professor Cristóbal Uauy has been appointed as the next Director of the John Innes Centre.

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Wednesday reported a loss of $49 million in its fourth quarter. The Pleasanton, California-based company said it had a ...